Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

News & Events

New Study: Sports coaches resources

Our type 1 diabetes community has said that one of the biggest challenges for young people participating in sport is that coaches do not know about or understand diabetes.

News & Events

In other news ....

Diabetes-related news, funding announcements and our latest published research.

News & Events

Student Scholarships

The Centre aims to improve the lives of young people living with diabetes by encouraging new and innovative research, researchers and translation

News & Events

New study: Managing T1D During Exercise in High-Level Athletes

The aim of this study is to describe the strategies used by competitive athletes with T1D to successfully manage their condition during sport and exercise.

News & Events

New Study: Understanding caregiver experiences for caring for a young child with T1D

We know that caring for a child with type 1 diabetes (T1D) can be incredibly challenging. We also know that caregivers of children with T1D experience high levels of distress and anxiety. We are looking to better understand what this experience is like for caregivers so that we can identify

News & Events

Diabetes Nutrition Videos

What is a Carboyhdrate - Diabetes Nutrition Video We know there is a lot of information out there about food and nutrition and that parents want to

Resources

View our wide range of resources including fact sheets, and help understanding autism.

Research

Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder

CDKL5 deficiency disorder (CDD) is a rare developmental and epileptic encephalopathy (DEE) associated with multiple impairments and comorbidities. Outcome measures for disease-modifying clinical trials for DEEs should measurably capture a spectrum of caregiver priorities and be externally validated.

Research

Convalescent plasma in hospitalised patients with COVID-19

Convalscent plasma (CP) was identified as a potential therapy for COVID-19 available early in the pandemic.